Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- 28 Patenting of CRISPR-based Inventions
- 29 Patent, Ownership and Licensing Issues of CRISPR-based Genome Editing: Impact on Universities and their Licensees
- 30 The Ethics of Human Genome Editing
- 31 Regulating Human Genome Editing: Negotiating Ethical Concerns Through Science and Policy
- Index
- Plate Section (PDF Only)
- References
29 - Patent, Ownership and Licensing Issues of CRISPR-based Genome Editing: Impact on Universities and their Licensees
from Part VI - Legal (Intellectual Property) and Bioethical Issues of Genome Editing
Published online by Cambridge University Press: 30 July 2018
Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- 28 Patenting of CRISPR-based Inventions
- 29 Patent, Ownership and Licensing Issues of CRISPR-based Genome Editing: Impact on Universities and their Licensees
- 30 The Ethics of Human Genome Editing
- 31 Regulating Human Genome Editing: Negotiating Ethical Concerns Through Science and Policy
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Genome Editing and EngineeringFrom TALENs, ZFNs and CRISPRs to Molecular Surgery, pp. 431 - 442Publisher: Cambridge University PressPrint publication year: 2018
References
Haeussler, M, Concordet, J. 2016. Genome editing with CRISPR-Cas9: can it get any better? J Genet Genom 43(5): 239–250.CrossRefGoogle ScholarPubMed
Jinek, M, Chylinski, K, Fonfara, I, et al. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816–821.CrossRefGoogle ScholarPubMed
Leahy-Smith America Invents Act. 2011. One Hundred Twelfth Congress of the United States of America, Public Law 112–29, September 16, 2011, 125 Stat 284.Google Scholar
Ledford, H. 2016. Bitter fight over CRISPR patent heats up. Nature 529: 265.CrossRefGoogle ScholarPubMed
Noonan, KE. 2016. CRISPR interference declared. Patent Docs. www.patentdocs.org/2016/01/crispr-interference-declared.html (accessed November 2017).Google Scholar
Sherkow, J. 2015. The CRISPR patent interference showdown is on: how did we get here and what comes next? Stanford Law School, Law and Biosciences Blog. https://law.stanford.edu/2015/12/29/the-crispr-patent-interference-showdown-is-on-how-did-we-get-here-and-what-comes-next/ (accessed November 2017).Google Scholar
Sibley, A, Sparks, R. 2009. The difficulty of determining joint inventorship, especially with regard to novel chemical compounds and their applications. Loyola Law Technol Annu 8(1): 44–62.Google Scholar
Sparks, R. 2008. Performing a preliminary assessment of patentability for a new invention: guidelines for non-patent lawyers. Int In-House Counsel J 2(5): 816–827.Google Scholar
Sparks, R. 2009. Unintended negative consequences of joint ownership of a patent. Int In-House Counsel J 3(9): 1411–1420.Google Scholar
Sparks, R, Park, S, Paschall, C. 2015. Recent patent legislation and court decisions in the United States: impact on validity of patents and on obtaining, licensing, and enforcing patents. Int In-House Counsel J 8(31):, 3369–3380.Google Scholar
Zhang, F, Zetsche, B, Slaymaker, I, Gootenberg, J, Abudayyeh, O. 2016. Novel CRISPR Enzymes and Systems. US Patent Application Number 14/975,085.Google Scholar